Duncan C. Gilbert
MRC Clinical Trials Unit at UCL(GB)University College London(GB)
Publications by Year
Research Areas
Colorectal and Anal Carcinomas, Prostate Cancer Treatment and Research, Testicular diseases and treatments, Cervical Cancer and HPV Research, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study(2020)599 cited
- → Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial(2019)395 cited
- → Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol(2018)246 cited
- → The efficacy of sales promotions in UK supermarkets: a consumer view(2002)215 cited
- → ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours(2016)162 cited
- → KIT and RAS signalling pathways in testicular germ cell tumours: new data and a review of the literature(2007)121 cited